Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK L.N. ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.2% 6.4% 10.9% 7.4% 4.5% 7.7% 11.7% 11.7%   Credit score (0-100)   58 39 24 34 46 30 20 19   Credit rating   BBB BBB BB BB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   276 0 0 0 0 0 0 0   Gross profit   276 82.0 -55.7 -48.9 -39.8 -67.7 0.0 0.0   EBITDA   -18.0 -40.7 -55.7 -48.9 -39.8 -67.7 0.0 0.0   EBIT   -18.0 -40.7 -55.7 -48.9 -39.8 -67.7 0.0 0.0   Pre-tax profit (PTP)   113.8 -17.0 58.0 -14.0 367.7 -412.8 0.0 0.0   Net earnings   110.6 -16.9 43.1 -14.1 286.6 -409.2 0.0 0.0   Pre-tax profit without non-rec. items   114 -17.0 58.0 -14.0 368 -413 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   2,667 2,650 2,693 2,679 2,966 2,557 2,432 2,432   Interest-bearing liabilities   0.0 0.0 0.0 0.0 596 611 0.0 0.0   Balance sheet total (assets)   3,365 3,273 3,171 3,189 3,562 3,167 2,432 2,432   Net Debt   -3,291 -3,249 -3,156 -3,184 -2,966 -2,557 -2,432 -2,432     See the entire balance sheet 1000.0 Volume  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   276 0 0 0 0 0 0 0   Net sales growth   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   276 82.0 -55.7 -48.9 -39.8 -67.7 0.0 0.0   Gross profit growth   0.0% -70.3% 0.0% 12.2% 18.6% -70.1% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,365 3,273 3,171 3,189 3,562 3,167 2,432 2,432   Balance sheet change%   0.0% -2.7% -3.1% 0.6% 11.7% -11.1% -23.2% 0.0%   Added value   -18.0 -40.7 -55.7 -48.9 -39.8 -67.7 0.0 0.0   Added value %   -6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A EBITDA %   -6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -6.5% -49.6% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   40.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   40.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   41.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.3% 2.2% 2.5% 0.3% 11.6% 0.2% 0.0% 0.0%   ROI %   5.4% 2.7% 3.0% 0.4% 13.9% 0.2% 0.0% 0.0%   ROE %   4.1% -0.6% 1.6% -0.5% 10.2% -14.8% 0.0% 0.0%   1000.0 Solidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Equity ratio %   79.3% 81.0% 84.9% 84.0% 71.3% 67.7% 100.0% 100.0%   Relative indebtedness %   252.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -939.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   18,296.3% 7,984.8% 5,663.5% 6,507.3% 7,445.7% 3,773.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 20.1% 23.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 8.3% 69.4% 0.0% 0.0%   1000.0 Liquidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Quick Ratio   4.8 5.3 6.6 6.2 3.0 2.6 0.0 0.0   Current Ratio   4.8 5.3 6.6 6.2 3.0 2.6 0.0 0.0   Cash and cash equivalent   3,290.8 3,249.3 3,155.6 3,184.0 3,561.6 3,167.4 0.0 0.0   1000.0 Capital use efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Trade debtors turnover (days)   55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   1,218.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -484.7 -530.2 -376.7 -419.7 -1,120.5 -1,189.4 0.0 0.0   Net working capital %   -175.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0